Cabaletta Bio (NASDAQ:CABA) Earns "Buy" Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. Other equities research analysts have also issued reports about the stock. Wells Fargo & Company increased their target price on […]

Related Keywords

California , United States , , Cabaletta Bio Inc , Citigroup , Westwood Holdings Group Inc , Cantor Fitzgerald , Cabaletta Bio Company Profile , Wells Fargo Company , Jefferies Financial Group , Pricet Rowe Associates Inc , Entrypoint Capital , Cabaletta Bio , Free Report , Financial Group , Bio Trading Down , Get Free Report , State Teachers Retirement System , Capital Management , Holdings Group , Cabaletta Bio Daily ,